
Isotretinoin 40 mg Capsules
Teva is recalling Isotretinoin 40 mg capsules due to superpotency and subpotency concerns that may affect treatment efficacy or safety.
Contact your pharmacist or healthcare provider to verify if your medication is affected and to discuss alternative treatment options. Do not stop taking your medication without consulting your doctor.
Why it was recalled
Superpotent and Subpotent
How to identify it
UPC 100075305 100075512 100076103
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
Where it was sold
Distributed in US-FL, US-MS, US-OH.
Official source
Other recent recalls from Teva Pharmaceuticals USA, Inc
Editorial summary by Recall Canary · last updated 2026-06-02 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
